Suchergebnisse - "Yan, Lun-Jie"

PubPharm (62)

1

The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2024

von Han, C. | Tian, B. | Yan, L. | +11

2

Neoadjuvant immunotherapy based on PD-1/L1 Inhibitors for gastrointestinal tumor : a review of rationale and clinical advances

enthalten in: International journal of surgery (London, England) | 2024

von Wang, D. | Liu, H. | Tian, J. | +7

3

Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts

enthalten in: International immunopharmacology | 2024

von Long, J. | Li, R. | Wang, D. | +10

4

Response to Letter Entitled "Re : Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis"

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Yan, L. | Yang, L. | Li, T.

CommentOn: Eur J Cancer. 2023 May;185:150-163. - PMID 36996625

5

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma : a systemic review and meta-analysis

enthalten in: Clinical and experimental medicine | 2023

von Tian, J. | Liu, H. | Yan, L. | +10

6

Caffeine intake is associated with less severe depressive symptoms in noncancer populations : an analysis based on NHANES 2007-2016

enthalten in: Nutrition research (New York, N.Y.) | 2023

von Yang, L. | Zhang, Z. | Yan, L. | +5

7

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

enthalten in: Biomarker research | 2023

von Mao, X. | Shi, S. | Yan, L. | +12

8

Regional and sex differences in the mortality risk associated with primary liver cancer in obesity : A systematic review and meta-analysis

enthalten in: Nutrition (Burbank, Los Angeles County, Calif.) | 2023

von Yang, L. | Yan, L. | Yan, Y. | +6

9

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

enthalten in: Cancer cell international | 2023

von Li, G. | Meng, G. | Pan, G. | +11

10

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

enthalten in: Cancer cell international | 2023

von Li, G. | Meng, G. | Pan, G. | +11

1
2
3
4
5
6
7
Nächster »
[7]